What's new

Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 12, Status: Authorised

May 5, 2025 - 15:57
 0
Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Trelegy Ellipta, fluticasone furoate,umeclidinium,vilanterol, Date of authorisation: 15/11/2017, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): HyQvia, human normal i...

Next Article

3G Capital to acquire Skechers for $8.2 billion

Related Posts

Human medicines European public assessment report (EPAR): Alprolix, eftrenonacog alfa, Date of authorisation: 12/05/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Regkirona, regdanvimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0